Kovai Medical Q1 FY27 Results: Revenue Rs 431 Cr, PAT Rs 69 Cr and Key Highlights
- August 12, 2026
- Posted by: Kunal Singla
- Category: News
Kovai Medical Q1 FY27 results declared August 7, 2026. Revenue Rs 431 Cr (+15.35% YoY). PAT Rs 69 Cr (+20.72% YoY). CMP Rs 5843.5 (-0.85%).
Kovai Medical Q1 FY27 results were declared on August 7, 2026, standalone. Revenue grew +15.35% YoY to Rs 431 Cr from Rs 373 Cr in Q1 FY26. The broader BSE Healthcare index reflected mixed sectoral sentiment during the quarter.
Operating profit stood at Rs 92 Cr (+15.44% YoY). PAT came in at Rs 69 Cr (+20.72% YoY), providing a detailed view of Kovai Medical Q1 FY27 results and business performance.
Click Here – Get Free Investment Predictions
Kovai Medical Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Kovai Medical Revenue | 431 | 373 | +15.35% |
| Operating Profit | 92 | 79 | +15.44% |
| Net Profit (PAT) | 69 | 57 | +20.72% |
| Reporting Basis | Standalone | ||
Kovai Medical Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Kovai Medical Q1 FY27 results reflect healthy fundamentals across key financial metrics. The top line showed resilience with revenue reaching Rs 431 Cr for the April to June 2026 quarter.
Operating profit expanded +15.44% YoY to Rs 92 Cr. Improving cost absorption and product mix optimisation contributed to the uptick.
PAT of Rs 69 Cr in Kovai Medical Q1 FY27 results marks a +20.72% YoY movement. Investors monitoring Kovai Medical Q1 FY27 results will note this as a key milestone for the FY27 earnings trajectory.
Key Business Factors in Kovai Medical Q1 FY27 Results
Revenue Growth Momentum in the Quarter
Kovai Medical Q1 FY27 results show top-line expansion of +15.35% YoY to Rs 431 Cr. Order book execution and market share gains in the Healthcare segment supported this trajectory.
Operating Margin Performance
Operating profit in Kovai Medical Q1 FY27 results improved to Rs 92 Cr (+15.44% YoY). Better product mix, cost discipline, and operating leverage contributed to the improvement.
PAT Trajectory and Profitability Outlook
PAT in Kovai Medical Q1 FY27 results stood at Rs 69 Cr (+20.72% YoY). The improving PAT trajectory signals strengthening financial health and returns on capital.
Dividend Details
No dividend was declared alongside Kovai Medical Q1 FY27 results. Earnings are being directed toward operational investments and working capital optimisation.
FY27 Outlook for Kovai Medical
Kovai Medical is positioned to sustain growth momentum through FY27 driven by order visibility, sector tailwinds, and operational improvements in the healthcare segment. Management guidance points toward continued focus on margin expansion. Investors tracking Kovai Medical Q1 FY27 results should consult a SEBI-registered financial advisor before making investment decisions.
Kovai Medical Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Kovai Medical live price and get daily stock recommendations.
Kovai Medical shares were trading lower at Rs 5843.5 (-0.85%) on August 7, 2026, reflecting investor sentiment on Kovai Medical Q1 FY27 results and the near-term sector outlook. The CMP of Rs 5843.5 on the results date reflects broader sentiment in the healthcare space.
Key Risks for Kovai Medical
Sector-Specific Risks
Rising operational costs and regulatory compliance for medical facilities.
Valuation and Earnings Risk
Valuation risk remains if quarterly growth momentum fails to sustain over the next two to three quarters.
Operational and Financial Risk
Working capital intensity and cash conversion cycle elongation could strain standalone cash flows.
Conclusion
Kovai Medical Q1 FY27 results reflect healthy performance with revenue at Rs 431 Cr and PAT at Rs 69 Cr on a Standalone basis. Sector tailwinds and operational discipline will determine the FY27 growth trajectory. Investors should review management commentary and quarterly data before taking any position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Kovai Medical Q1 FY27 Results
When were Kovai Medical Q1 FY27 results declared?
Ans. Kovai Medical Q1 FY27 results were declared on August 7, 2026, covering the April–June 2026 quarter on a Standalone basis.
What was Kovai Medical revenue in Q1 FY27?
Ans. Kovai Medical Q1 FY27 results show revenue of Rs 431 Cr, +15.35% compared to Rs 373 Cr in Q1 FY26.
What was Kovai Medical PAT in Q1 FY27?
Ans. Net profit in Kovai Medical Q1 FY27 results was Rs 69 Cr, +20.72% year-on-year.
Did Kovai Medical declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Kovai Medical Q1 FY27 results. Check official NSE and BSE announcements for updates.
What is the FY27 outlook for Kovai Medical?
Ans. Management has guided revenue growth and margin improvement for FY27. Sector trends will remain key monitorables.
How did Kovai Medical stock react to Q1 FY27 results?
Ans. Kovai Medical shares were lower at Rs 5843.5 (-0.85%) on August 7, 2026. Consult a SEBI-registered advisor before acting on price movements.
